Journal article 557 views 78 downloads
Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex
,
Daniel Harris,
Arron S. Lacey ,
Ashley Akbari ,
Fatemeh Torabi ,
Dave Smith ,
Geraint Jenkins ,
Daniel Obaid ,
Alexander Chase,
Ann John ,
Michael Gravenor ,
Julian Halcox
PLOS ONE, Volume: 17, Issue: 2, Start page: e0264529
Swansea University Authors:
Libby Ellins , Daniel Harris, Arron S. Lacey , Ashley Akbari , Fatemeh Torabi , Daniel Obaid , Alexander Chase, Ann John , Michael Gravenor , Julian Halcox
-
PDF | Version of Record
© 2022 Ellins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License
Download (1003.3KB)
DOI (Published version): 10.1371/journal.pone.0264529
Abstract
AimsTo explore differences in the use of lipid lowering therapy and/or achievement of lipid guideline targets in patients with and without prior depression and influence of sex in very high-risk coronary patients.Methods & findingsA retrospective observational cohort study was conducted using in...
| Published in: | PLOS ONE |
|---|---|
| ISSN: | 1932-6203 |
| Published: |
Public Library of Science (PLoS)
2022
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa59420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
AimsTo explore differences in the use of lipid lowering therapy and/or achievement of lipid guideline targets in patients with and without prior depression and influence of sex in very high-risk coronary patients.Methods & findingsA retrospective observational cohort study was conducted using individual-level linked electronic health record data in patients who underwent percutaneous coronary intervention (2012–2017) in Wales. The cohort comprised of 13,781 patients (27.4% female), with 26.1% having prior depression. Lipid levels were recorded in 10,050 patients of whom 25% had depression. History of depression was independently associated with not having lipids checked (OR 0.79 95%CI 0.72–0.87 p<0.001). Patients with prior depression were less likely to achieve targets for low density lipoprotein cholesterol (LDL-C <1.8mmol/l), non-high density lipoprotein cholesterol (non-HDL-C <2.6mmol/l) and triglycerides (<2.3mmol/l) than patients without depression (OR 0.86 95%CI 0.78–0.96 p = 0.007, OR 0.80 95%CI 0.69–0.92 p = 0.003 & OR 0.69 95CI% 0.61–0.79 p<0.001 respectively). Females were less likely to achieve targets for LDL-C and non-HDL-C than males (OR 0.55 95%CI 0.50–0.61 p<0.001 & OR 0.63 95%CI 0.55–0.73 p<0.001). There was an additive effect of depression and sex; females with depression were not only least likely to be tested (OR 0.74 95%CI 0.65–0.84 p<0.001) but also (where levels were known) less likely to achieve LDL-C (OR 0.47 95%CI 0.41–0.55 p<0.001) and non-HDL-C targets (OR 0.50 95%CI 0.41–0.60 p<0.001). It was not possible to look at the influence of medication adherence on achievement of lipid targets due to limitations of the use of anonymised routinely-held clinical care data.ConclusionPatients with prior depression were less likely to have their lipids monitored and achieve guideline targets within 1-year. Females with depression are the least likely to be tested and achieve lipid targets, suggesting not only a greater risk of future events, but also an opportunity to improve care. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
This work was supported by Health Data Research UK (www.hdruk.ac.uk), which receives its funding from Health Data Research United Kingdom Ltd (HDR-9006) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF), and the Wellcome Trust (AA, JH, FT & AL). DH was also supported by Swansea Bay University Health Board Research and Development Department (https://sbuhb.nhs.wales/hospitals/a-z-hospital-services/researchand-development/). |
| Issue: |
2 |
| Start Page: |
e0264529 |